Search Results - Hongfen Guo

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    A potent tetravalent T-cell–engaging bispecific antibody against CD33 in acute myeloid leukemia by Sayed Shahabuddin Hoseini, Hongfen Guo, Zhihao Wu, Miho Nakajima Hatano, Nai-Kong V. Cheung

    Published in Blood Advances (2018-06-01)
    Get full text
    Article


  2. 2

    Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinoma by Alan W Long, Hong Xu, Brian H Santich, Hongfen Guo, Sayed Shahabuddin Hoseini, Elisa de Stanchina, Nai-Kong V Cheung

    Published in Journal of Hematology & Oncology (2024-04-01)
    Get full text
    Article


  3. 3

    Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33/IL1RL1 pathway by Denggang Fu, Hua Jiang, Alan Long, Ella Harris, Hongfen Guo, Maegan L. Capitano, John Wrangle, Joshua R. Faust, Anilkumar Gopalakrishnapillai, Santhosh Kumar Pasupuleti, Baskar Ramdas, Reuben Kapur, Sonali P. Barwe, Nai-Kong V. Cheung, Sophie Paczesny

    Published in Nature Communications (2025-07-01)
    Get full text
    Article


  4. 4

    ST2/IL-33 axis blockade inhibits regulatory T cell cytotoxicity towards CD8 T cells in the leukemic niche by Hua Jiang, Denggang Fu, Santhosh Kumar Pasupuleti, Baskar Ramdas, Alan Long, Abdulraouf M. Ramadan, Jinfeng Yang, Ramesh Kumar, Jessica H. Hartman, B. Jacob Kendrick, Ed Simpson, Hongyu Gao, Yunlong Liu, Drew Moore, Suganya Subramanian, Stefano Berto, Anilkumar Gopalakrishnapillai, Sonali P. Barwe, Hongfen Guo, Nai-Kong V. Cheung, Reuben Kapur, Sophie Paczesny

    Published in Nature Communications (2025-07-01)
    Get full text
    Article


Search Tools: